Sintilimab After Concurrent Chemoradiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma
NCT06413342
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
191
Enrollment
OTHER
Sponsor class
Conditions
Esophageal Cancer
Chemoradiotherapy
Sintilimab
Immunotherapy
Elderly Patients
Interventions
DRUG:
Sintilimab
Sponsor
Zhejiang Cancer Hospital